These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 24740818)
1. Exogenous fatty acid binding protein 4 promotes human prostate cancer cell progression. Uehara H; Takahashi T; Oha M; Ogawa H; Izumi K Int J Cancer; 2014 Dec; 135(11):2558-68. PubMed ID: 24740818 [TBL] [Abstract][Full Text] [Related]
2. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway. Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646 [TBL] [Abstract][Full Text] [Related]
3. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway. Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863 [TBL] [Abstract][Full Text] [Related]
4. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related]
5. FABP4 reversed the regulation of leptin on mitochondrial fatty acid oxidation in mice adipocytes. Gan L; Liu Z; Cao W; Zhang Z; Sun C Sci Rep; 2015 Aug; 5():13588. PubMed ID: 26310911 [TBL] [Abstract][Full Text] [Related]
6. Palmitic acid inhibits prostate cancer cell proliferation and metastasis by suppressing the PI3K/Akt pathway. Zhu S; Jiao W; Xu Y; Hou L; Li H; Shao J; Zhang X; Wang R; Kong D Life Sci; 2021 Dec; 286():120046. PubMed ID: 34653428 [TBL] [Abstract][Full Text] [Related]
7. Fatty acid binding protein 4 promotes epithelial-mesenchymal transition in cervical squamous cell carcinoma through AKT/GSK3β/Snail signaling pathway. Jin J; Zhang Z; Zhang S; Chen X; Chen Z; Hu P; Wang J; Xie C Mol Cell Endocrinol; 2018 Feb; 461():155-164. PubMed ID: 28893569 [TBL] [Abstract][Full Text] [Related]
8. FAM9C plays an anti-apoptotic role through activation of the PI3K/Akt pathway in human hepatocellular carcinoma. Zhou JD; Shen F; Ji JS; Zheng K; Huang M; Wu JC Oncol Rep; 2013 Sep; 30(3):1275-84. PubMed ID: 23836295 [TBL] [Abstract][Full Text] [Related]
9. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer. Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873 [TBL] [Abstract][Full Text] [Related]
10. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4. Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483 [TBL] [Abstract][Full Text] [Related]
11. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways. Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174 [TBL] [Abstract][Full Text] [Related]
12. Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins. Guaita-Esteruelas S; Bosquet A; Saavedra P; Gumà J; Girona J; Lam EW; Amillano K; Borràs J; Masana L Mol Carcinog; 2017 Jan; 56(1):208-217. PubMed ID: 27061264 [TBL] [Abstract][Full Text] [Related]
13. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138 [TBL] [Abstract][Full Text] [Related]
14. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer. Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137 [TBL] [Abstract][Full Text] [Related]
15. Novel lipogenic enzyme ELOVL7 is involved in prostate cancer growth through saturated long-chain fatty acid metabolism. Tamura K; Makino A; Hullin-Matsuda F; Kobayashi T; Furihata M; Chung S; Ashida S; Miki T; Fujioka T; Shuin T; Nakamura Y; Nakagawa H Cancer Res; 2009 Oct; 69(20):8133-40. PubMed ID: 19826053 [TBL] [Abstract][Full Text] [Related]
16. PI3K-AKT-mTOR pathway is dominant over androgen receptor signaling in prostate cancer cells. Kaarbø M; Mikkelsen OL; Malerød L; Qu S; Lobert VH; Akgul G; Halvorsen T; Maelandsmo GM; Saatcioglu F Cell Oncol; 2010; 32(1-2):11-27. PubMed ID: 20203370 [TBL] [Abstract][Full Text] [Related]
17. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy. Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933 [TBL] [Abstract][Full Text] [Related]
18. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma. Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway. Miyake H; Nelson C; Rennie PS; Gleave ME Endocrinology; 2000 Jun; 141(6):2257-65. PubMed ID: 10830316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]